1. �Ͼ�ҽ�ƴ�ѧ��������������ҽԺƤ����
2. �Ͼ�ҽ�ƴ�ѧ��������������ҽԺ

PTEN������һ���ְ�������ȱʧ��ͻ��ͱ����ٿɴ��ڶ���Ƥ�������С�PTEN������Ҫͨ��PI3K/Akt��FAK/p130;����Shc/ras/MARK;��Ӱ��ϸ���ķֻ����������ƶ����ź�ת���ȷ��棬����Ƥ�������ķ�����չ����Ƥ�������Ķ���ת���������еĹ�ϵ����ˣ�PTEN�����ڱ���Ƥ���ڻ����ȶ�������Ƥ�������ķ�������������Ҫ�����á����������߷����PTEN���ܵĵ��ڼ�PTEN�����ڶ���Ƥ������������չ�е����á�

Phosphatase and tensin homolog deleted on chromosome 10 ��PTEN��, a tumor suppressor gene, is frequently deleted, mutated or lowly expressed in various skin tumors. It takes part in the initiation and development of skin tumors and is involved in the malignant transformation of skin tumors by affecting cell differentiation, apoptosis, migration and signal transduction mainly through PI3K/Akt pathway, FAK/p130 pathway and Shc/ras/MARK pathway. Therefore, PTEN gene plays an important role in maintaining the stability of internal environment of skin and inhibiting the development of skin tumors. This review summarizes the regulation of PTEN gene by ultraviolet irradiation and the role of PTEN gene in the initiation and development of skin tumors.

null

[1]�Ա�.�ٴ�Ƥ����ѧ.3��.�Ͼ�:���տƼ�������,2001: 123.] [2] Shim JH, Kim YS, Bahk YY. Proteome profile changes that are differentially regulated by lipid and protein phosphatase activities of tumor suppressor PTEN in PTEN-expressing U-87 MG human glioblastoma cells .Proteomics,2006,6(1):81-93. [3]N. R. Gough. PI3K-Independent Function of PTEN. Sci.Signal.2009, 2(94): 346. [4]Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997, 275(5308): 1943-1947. [5]Waite KA , Eng C. Protein PTEN: form and function . Am J Hum Genet , 2002,70 (4):829-844. [6]Kuhajda FR. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res, 2006, 66(12):5977-5980. [7]Hagenbeek TJ, Naspetti M, Malergue F, et al. The loss of PTEN allows TCR lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling. J Exp Med, 2004, 200(7):883- 894. [8]Li X, Lin G, Wu B, et al. Overexpression of PTEN induces cell growth arrest and apop tosis in human breast cancer ZR-75-1cells. Acta Biochim Biophys Sin ( Shanghai) , 2007, 39(10) : 745. [9]Patrawala L, Calhoun T, Schneider - Broussard R, et al. Side population is enriched in tumorigenic, stem- like cancer cells, whereas ABCG2 + and ABCG2 - cancer cells are similarly tumorigenic. Cancer Res, 2005, 65(14): 6207-6219. [10]Reifenberger J. Basal cell carcinoma. Molecular genetics and unusual clinical features. Hautarzt, . 2007,58(5):406–411. [11]Hill R,Wu H.PTEN, stem cells, and cancer stem cells. J Biol Chem,2009,284(18): 11755- 11759. [12]He YY, Pi J, Huang JL, et al. Chronic UVA irradiation of human HaCaT keratinocytes induces malignant transformation associated with acquired apoptotic resistance. Oncogene, 2006,25(26): 3680–3688. [13]Backman SA, Ghazarian D, So K, et al. Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc Natl Acad Sci USA, 2004, 101(6): 1725–1730. [14]He XC, Yin T, Grindley JC, et al. PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet,2007,39(2):189–198. [15] Shen WH, Balajee AS, Wang J, et al. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell. 2007,128(1):157–170. [16]Alireza Mirmohammadsadegh, Alessandra Marini, Sandeep Nambiar, et al. Epigenetic Silencing of the PTEN Gene in Melanoma. Cancer Res,2006,66(13):6546-6552. [17]Russo AE, Torrisi E, Bevelacqua Y, et al. Melanoma: molecular pathogenesis and emerging target therapies. Int J Oncol,2009,34(6):1481-1489. [18]Waldmann V ,Wacker J ,Deichmann M. Absence of mutations in the pleckstrin homology (PH) domain of protein kinase B (PKB/ Akt) in malignant melanoma. Melanoma Res ,2002,12(1): 45. [19]Hocker T, Tsao H. Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants. Hum Mutat,2007,28(6):578–588. [20]He YY, Pi J, Huang JL, et al. Chronic UVA irradiation of human HaCaT keratinocytes induces malignant transformation associated with acquired apoptotic resistance. Oncogene, 2006,25(26): 3680–3688. [21]Oh JH, Kim A, Park JM, et al. Ultraviolet B-induced matrix metalloproteinase-1 and -3 secretions are mediated via PTEN/Akt pathway in human dermal fibroblasts. J Cell Physiol, 2006,209(3):775–785. [22]Gimm O, Perren A, Weng LP, et al. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol, 2000, 156(5):1693–1700.